Sat September 26 - Sat October 3, 2020 Greenwich, CT 06830 US
Events
Virtual Walk - $25/Adult, 22+

Virtual 2 Mile Walk at Tods Point or Wherever You Choose - Adult, 22 years old & up

$25 Registration ends October 3, 2020 at 11:00am EDT
Virtual Walk - $10/Youth, 10-21yo

Virtual 2 Mile Walk at Tods Point or Wherever You Choose - 10 years old to 21 years old

$10 Registration ends October 3, 2020 at 12:00pm EDT
Walk - Under 10yo - FREE

Virtual 2 Mile Walk - Under 10yo - Free

$0 Registration ends October 3, 2020 at 12:00pm EDT
Place
Tods Point in Old Greenwich, or anywhere that's good for you!
Greenwich, CT US 06830
Description

Like many other organizations, for the safety of our supporters and our volunteers, DART has decided that this year's DART TO THE FINISH charity walk will be a "Virtual Walk."

We encourage you to walk around Tods Point yourself, or in small, socially distanced groups for the invigorating 2 mile walk around beautiful Tod's Point in Old Greenwich.  Of course, you can now do your walk anywhere; around your own neighborhood (from Connecticut to California), or on a treadmill at the gym or at home.

We've added a REWARDS program to encourage adult referrals AND benefit some of our local restaurants who have been long standing supporters of DART.  So please reach out to your family and friends, and encourage them to sign up and support us.

Urgent funds are still needed and the children are counting on us all to continue the amazing progress in NP-C research and treatment trials!

*When you register for our virtual walk, if you elect to pick-up your t-shirts, they will be available starting on Thursday, September 24, 2020 at Threads and Treads, 17 East Putnam Avenue, Greenwich, CT 06830.

 

If you are going to Tods Point; a reminder that no dogs allowed at Tods Point by the Town of Greenwich at this time of year.

DART TO THE FINISH Referral Reward Program!
  • Sign up for this year's DART TO THE FINISH "Virtual" Charity Walk.
  • Once your registration is complete, you will receive a unique referral link to share with your friends, family or post on social media
  • Get 5 friends to sign up using your unique referral link and you will automatically receive a gift certificate of $25.00 to your choice of one of our local restaurants; each of whom has been a generous supporter of DART over the years.
  • Get 10 or more friends to sign up using your unique referral link and you will automatically receive a second gift certificate of $25.00 to your choice of one of our local restaurants; each of which has been a generous supporter of DART over the years.
  • Keep Sharing and Promoting your link
Race Contact Info
If you have any questions about this race, please contact the race director at
Our Generous Sponsors - Updated from time to time.

 

Platinum/Presenting Sponsor:

 

Mallinckrodt Pharmaceuticals

Silver Sponsors:

   


 

About Dana's Angels Research Trust

Dana’s Angels Research Trust is a non-profit organization that funds research into a rare disease, Niemann-Pick type C (NPC), a fatal, cholesterol-storage disease affecting children.  Two of the Marella’s four children, Dana and Andrew, were afflicted by NPC.  Most children who suffer from NPC die in their early teens, but DART has helped change that fate.  As an all-volunteer organization, over 95% of the funds expended are channeled directly into supporting pivotal NPC research; research that may also help millions of people suffering from HIV/Aids, heart disease, stroke, Alzheimer’s disease  and other disorders that appear to be related to cholesterol.

Sadly, the Marella’s daughter, Dana, 19, passed away in the Summer of 2013.  When Dana died, she was confined to a wheelchair, no longer talked, suffered from frequent pneumonia and required constant care, but she always had a smile on her face and was an inspiration to many, both here and around the world.  The Marella’s youngest child, Andrew, who turns 21 on June 3, 2020, is relatively stable right now, although with the passing of his sister, Andrew struggles with seizures.  Andrew has benefited from two experimental medications and is a patient in the latest drug trial that started at the NIH and is now being taken forward by Mallinckrodt Pharmaceuticals, all due in large part to the supporters of DART.

About Niemann-Pick type C Disease and its Research Benefits

Niemann-Pick type C (NPC) is a rare genetic disease.  But there is strong interest in studying NPC from researchers in many fields because of its connection to cholesterol metabolism.  Research has shown that studying NPC may unlock the mysteries related to more common diseases affecting millions.

HIV/AIDS and Ebola:  The NPC protein is critical for the normal trafficking of cholesterol in all of the cells in our bodies.  Research shows that chemical creation of the NPC defect in diseases like HIV and Ebola results in drastically reduced infection, indicating that the NPC protein associated with cholesterol trafficking is required for infection.

Alzheimer’s:  Alzheimer’s and NPC are progressive neurological diseases with similar effects on the brain.  Recent studies comparing the two diseases discovered that Alzheimer’s is closely tied to a failure in cholesterol metabolism – the very process that is central to NPC.

Heart Disease and Stroke:  We all know that high cholesterol is the main cause of heart disease and stroke.  But until the gene that causes NPC was discovered, researchers had few opportunities to identify the complex processes that regulate cholesterol.  How does the body know if it has too much cholesterol or too little?  NPC research is beginning to provide answers.

A SAMPLE COURSE AT BEAUTIFUL TODS POINT, OLD GREENWICH, CT

ImageSELECT VIEW COURSE MAP BELOW FOR A SAMPLE COURSE

MapMyRun Map
Facebook

Like this page and invite your friends on Facebook.
Join this event and invite your friends on Facebook.

Race Participant Survey

Please complete the following survey to help us better understand your race experience.

Did you participate in the race?

Would you recommend this race to a friend?

We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy. If you continue to use this site, you consent to use all cookies.